National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Discover what non-reactive HIV test results really mean and why testing timing, window periods, and retesting are crucial for ...

The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?

Learn what a negative HIV test means, why the window period matters, and when you should consider retesting. Essential health ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...